David C. Kaslow

David C.
Kaslow, M.D., joined as Chief Scientific Officer in October 2001.
Dr. Kaslow has more than 15 years of vaccine research experience.
Dr. Kaslow joined Merck in February 1999 as Senior Director, Vaccine Research, and was employed by Merck, most recently as Head of the Department of Vaccine Research and Technology, until he joined Vical.
From 1986 to 1999, he held various senior research positions at the NIH, including Head of the Recombinant Protein Development Unit and the Malaria Vaccine Development Unit at the Laboratory of Parasitic Diseases.
Dr. Kaslow has been awarded numerous professional honors, including the U.S.
Public Health Service Outstanding Service Medal.
He has published more than 120 scientific papers, and authored more than 20 review articles and book chapters.
He holds or co-holds 13 patents.
Dr. Kaslow received his M.D.
from the School of Medicine at the University of California, San Francisco, in 1983 and his bachelor's degree from the University of California, Davis, in 1979.